RT Journal Article
SR Electronic
T1 A Systematic Review and Meta-analysis for Association of Celiac Disease and Thyroid Disorders
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.01.26.24301845
DO 10.1101/2024.01.26.24301845
A1 Norouzi, Zahra
A1 Hasani, Fatemeh
A1 Besharat, Sima
A1 Shirzad-Aski, Hesamaddin
A1 Ghorbani, Somayeh
A1 Mohammadi, Masoud
A1 Yadegari, Anahita
A1 Kalhori, Ali
YR 2024
UL http://medrxiv.org/content/early/2024/01/28/2024.01.26.24301845.abstract
AB It is probable that people who have celiac disease (CD) are more likely to have thyroid disorders. A comprehensive systematic review and meta-analysis were conducted to assess the link between thyroid disorders and CD. Articles were selected from PubMed, Web of Science, Scopus, Ovid, Embase, Cochrane, ProQuest, and Wiley from February 2022 and earlier. A meta-analysis was conducted to evaluate the outcomes, using odds ratios (ORs) and corresponding 95% confidence intervals (95% CIs). The meta-analysis comprised 31 articles with 3310256 participants including 101253 individuals with thyroid disorders. Overall, the frequency of thyroid disease was notably higher in patients with CD compared to the control groups (OR: 3.06, 95% CI: 2.51 – 3.72, P<0.001). The findings of our meta-analysis support the notion that patients with CD are more likely to have autoimmune thyroid disease (ATD) and other thyroid disorders than the control group, thus indicating that regular screening for thyroid disease is necessary for CD patients. Further cohort research is required to investigate the relationship between thyroid disorders and CD.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNClinical ProtocolsNFunding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:not applicableI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Not ApplicableAll relevant data are within the manuscript and its Supporting Information files. N CDCeliac diseaseOROdds ratioCIConfidence intervalATDAutoimmune thyroid diseaseTPOThyroid peroxidaseTGThyroglobulinTSHThyroid-stimulating hormonePRISMAPreferred Reporting Items for Systematic Reviews and Meta-AnalysesRRRisk ratioHRHazard ratioNOSNewcastle-Ottawa ScaleCTLA-4Cytotoxic T lymphocytes is related to antigen 4